US Varicose Vein Treatment Market

Market Overview

The US Varicose Vein Treatment Market size is projected to reach USD 711.9 million in 2026 and grow at a compound annual growth rate of 6.5%, reaching USD 1,252.8 million by 2035.

ℹ To learn more about this report – Download Your Free Sample Report Here

Varicose vein treatment includes medical and cosmetic procedures used to address enlarged and twisted veins caused by venous insufficiency and poor blood circulation, primarily in the legs. It involves minimally invasive options such as endovenous laser therapy, radiofrequency ablation, and sclerotherapy, along with surgical methods and compression therapy to relieve pain, improve blood flow, and enhance appearance.

The US varicose vein treatment market reflects a mature healthcare segment, driven by rising cases of chronic venous disease, increasing preference for minimally invasive outpatient procedures, growing awareness, and a strong presence of advanced technologies and specialty vein clinics, supported by favorable reimbursement systems.

ℹ To learn more about this report – Download Your Free Sample Report Here

The US Varicose Vein Treatment Market: Key Takeaways and Other Influencing Factors

• Strong Market Growth: Market projected at USD 711.9 million in 2026, reaching USD 1,252.8 million by 2035, driven by rising procedure demand.
• Sclerotherapy Dominance: Sclerotherapy leads with 46.0% share in 2026 due to cost effectiveness and high use in outpatient care.
• Hospitals Lead Usage: Hospitals hold 38.0% share, supported by advanced infrastructure and higher complex case volumes.
• Minimally Invasive Shift: Over 80% of procedures are minimally invasive, reflecting strong adoption of laser and catheter based treatments.
• High Disease Burden (CDC): Around 900,000 venous thromboembolism cases annually in the US, indicating strong treatment demand.
• Widespread Prevalence (NIH): Up to 30% of the US population is affected by varicose veins, driving long term market need.
• Chronic Conditions Impact (CDC): About 51.4% of adults had multiple chronic conditions in 2023, increasing vascular disease risk.

The US Varicose Vein Treatment Market: Use Cases

• Cosmetic Vein Removal and Aesthetic Enhancement: Varicose vein treatments are widely used for cosmetic improvement, especially for spider veins and visible leg veins. Procedures such as sclerotherapy and laser vein treatment help improve skin appearance, boost patient confidence, and support the growing demand for aesthetic dermatology and non-surgical cosmetic procedures in the US.
• Chronic Venous Insufficiency Management: Treatment solutions play a critical role in managing chronic venous insufficiency by improving venous blood flow and reducing symptoms like leg pain, swelling, and heaviness. Minimally invasive techniques such as endovenous ablation and radiofrequency therapy are commonly used to restore vein function and prevent disease progression.
• Outpatient and Ambulatory Care Procedures: Varicose vein treatments are increasingly performed in outpatient settings such as ambulatory surgical centers and specialty vein clinics. These minimally invasive procedures offer shorter recovery time, lower healthcare costs, and high patient convenience, supporting the shift toward same day treatment models in the US healthcare system.
• Prevention of Venous Ulcers and Complications: Advanced vein treatment helps prevent severe complications such as venous leg ulcers, blood clots, and skin discoloration. Early intervention through ultrasound-guided procedures and compression therapy improves long term vascular health and reduces hospital admissions related to untreated venous disorders.

Impact of Iran Conflict on the US Varicose Vein Treatment Market

The Iran conflict is disrupting global medical supply chains, increasing costs of devices used in varicose vein treatments in the US. Trade route instability is raising logistics and raw material expenses, impacting pricing of minimally invasive equipment. The US market remains relatively resilient due to strong domestic healthcare infrastructure and diversified sourcing. However, prolonged instability may slightly slow market growth due to cost pressures and supply uncertainties.

The US Varicose Vein Treatment Market: Market Dynamics

Driving Factors in the US Varicose Vein Treatment Market

Rising Adoption of Minimally Invasive Vein Procedures
Growing preference for minimally invasive treatments such as endovenous laser therapy and radiofrequency ablation is driving market expansion. These techniques offer faster recovery time, reduced pain, and improved clinical outcomes, increasing patient demand for outpatient vein treatment and non-surgical vascular procedures in the US.

Increasing Prevalence of Chronic Venous Disorders
The rising incidence of chronic venous insufficiency, varicose veins, and related vascular conditions due to aging population and sedentary lifestyles is boosting treatment demand. Higher awareness, early diagnosis, and access to advanced vein care solutions are further supporting market growth.

Restraints in the US Varicose Vein Treatment Market

High Cost of Advanced Treatment Technologies
The cost of laser based systems, catheter devices, and image guided procedures remains high, limiting accessibility for some patient groups. This impacts adoption of advanced varicose vein treatment options, especially where insurance coverage is limited.

Limited Coverage for Cosmetic Procedures
Many insurance providers classify vein treatments as aesthetic procedures, restricting reimbursement. This reduces patient affordability for treatments like sclerotherapy and cosmetic vein removal, slowing market penetration.

Opportunities in the US Varicose Vein Treatment Market

Expansion of Specialty Vein Clinics
The rapid growth of vein clinics and ambulatory care centers creates opportunities for increased procedure volumes. These facilities focus on outpatient vascular treatments, offering cost effective and patient centric care with advanced diagnostic imaging.

Technological Advancements in Treatment Devices
Innovations in laser therapy systems, ultrasound guided techniques, and catheter based solutions are enhancing treatment precision and efficiency. These advancements are enabling safer procedures, improved patient outcomes, and wider adoption across the US healthcare system.

Trends in the US Varicose Vein Treatment Market

Shift toward Outpatient and Same Day Procedures
There is a strong trend toward outpatient vein treatment in ambulatory surgical centers due to convenience and reduced hospital stays. Same day discharge and minimally invasive care models are becoming standard across the US.

Growing Demand for Aesthetic and Preventive Care
Increasing focus on cosmetic dermatology and preventive vascular care is shaping market trends. Patients are opting for early stage treatment of spider veins and venous disease, supported by rising awareness and lifestyle driven healthcare decisions.

The US Varicose Vein Treatment Market: Research Scope and Analysis

By Treatment Type Analysis

Sclerotherapy is anticipated to dominate the treatment type segment, capturing 46.0% of the total market share in 2026, primarily due to its widespread use in treating spider veins and small varicose veins through a cost-effective, minimally invasive approach with high patient preference and quick recovery time, making it a first line option in outpatient vein care.

ℹ To learn more about this report – Download Your Free Sample Report Here

The procedure's ease of administration, repeatability, and strong presence in cosmetic vein treatment further strengthen its adoption across specialty clinics in the US. Meanwhile, endovenous ablation continues to gain significant traction for treating larger and more complex venous conditions, supported by advanced technologies such as laser and radiofrequency ablation that offer improved precision, reduced recurrence rates, and enhanced clinical outcomes, positioning it as a rapidly growing segment within minimally invasive vascular treatment solutions.

By End User Analysis

Hospitals are anticipated to dominate the end user segment, capturing 38.0% of the total market share in 2026, driven by their advanced healthcare infrastructure, availability of skilled vascular specialists, and ability to manage complex varicose vein cases requiring comprehensive diagnostic imaging and surgical intervention, along with strong reimbursement support and higher patient inflow. Hospitals also serve as primary centers for treating severe chronic venous insufficiency and related complications, ensuring consistent demand. Meanwhile, specialty clinics are gaining strong momentum due to their focus on minimally invasive vein treatments such as sclerotherapy and endovenous procedures, offering cost effective, outpatient based care with shorter waiting times, personalized treatment plans, and increasing patient preference for convenient and targeted vascular care services in the US.

The US Varicose Vein Treatment Market Report is segmented on the basis of the following:

By Treatment Type

• Endovenous Ablation
• Sclerotherapy
• Surgical Procedures
• Compression Therapy

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Impact of Artificial Intelligence in the US Varicose Vein Treatment Market

Artificial intelligence is enhancing the US varicose vein treatment market by improving diagnostic accuracy through advanced imaging and ultrasound-guided vein mapping. It supports personalized treatment planning by identifying suitable procedures such as sclerotherapy or endovenous ablation.

AI-driven tools also improve procedural precision and reduce complications in minimally invasive treatments. Additionally, it streamlines clinical workflows and enables predictive analytics for better outcomes. The technology is driving efficiency, faster recovery, and more data-driven vascular care solutions.

The US Varicose Vein Treatment Market: Competitive Landscape

The US varicose vein treatment market is highly competitive, characterized by the presence of established players and emerging providers focusing on minimally invasive technologies and advanced vascular care solutions. Companies compete on innovation, product portfolio expansion, and adoption of laser and radiofrequency-based treatment systems to enhance clinical outcomes.

ℹ To learn more about this report – Download Your Free Sample Report Here

Strategic collaborations, technological advancements, and expansion of outpatient and specialty clinic networks are key competitive strategies. The market is also witnessing increasing emphasis on cost efficiency, patient-centric care, and differentiation through advanced diagnostic and treatment capabilities.

Some of the prominent players in the US Varicose Vein Treatment Market are:

• Medtronic
• AngioDynamics
• Boston Scientific
• Teleflex Incorporated
• Merit Medical Systems
• LeMaitre Vascular
• Venclose Inc.
• VVT Medical Ltd.
• Candela Corporation
• Sciton Inc.
• Lumenis Be Ltd.
• biolitec AG
• Quanta System
• Eufoton S.r.l.
• Energist Ltd.
• Dornier MedTech
• Theraclion SA
• Alma Lasers Ltd.
• Syneron Medical Ltd.
• USA Vein Clinics
• Other Key Players

Recent Developments in the US Varicose Vein Treatment Market

• January 2026: Boston Scientific announced the acquisition of Penumbra in a deal valued at approximately USD 11 billion to strengthen its vascular and interventional treatment portfolio, enhancing capabilities relevant to minimally invasive vein procedures.
• January 2026: Theraclion advanced its Sonovein robotic focused ultrasound system, a non-invasive treatment for varicose veins, highlighting next generation product innovation in the market.
• November 2025: W. L. Gore & Associates introduced the GORE VIABAHN FORTEGRA venous stent, demonstrating strong clinical outcomes for treating deep venous obstruction and supporting innovation in vein treatment devices.

Report Details